We next investigated enrichment of the Arc interactome for rare point mutations and indels contributing to brain disorders, using exome sequencing data from a case/control schizophrenia study (Purcell et al., 2014) and de novo studies performed in cohorts of schizophrenia, autism, ID, and epilepsy (Supplemental Experimental Procedures). This evidence concerns the gene ARC and brain disorder.